Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Business

AstraZeneca’s £450 million vaccine plant at risk as government reconsiders financial backing

by August 15, 2024
August 15, 2024
AstraZeneca’s £450 million vaccine plant at risk as government reconsiders financial backing

The Treasury has reassured that it remains in “positive discussions” with AstraZeneca regarding the pharmaceutical giant’s proposed £450 million vaccine manufacturing facility in northwest England.

However, doubts have emerged following reports that the government is considering reducing its financial support for the project to £40 million—a significant cut from the £65 million reportedly promised by former chancellor Jeremy Hunt.

This investment, along with a separate £200 million expansion of AstraZeneca’s global research and development hub in Cambridge, was highlighted by Hunt in his March budget speech. At the time, he praised AstraZeneca as “one of our greatest life science companies,” led by the “irrepressible” Sir Pascal Soriot.

Although Soriot, AstraZeneca’s CEO, has expressed confidence in UK life sciences, he has also voiced concerns about the country’s business and fiscal environment. Following Labour’s recent election victory, the Treasury, under new Chancellor Rachel Reeves, is reviewing spending decisions made by the previous government, including those related to AstraZeneca’s expansion plans.

Local MP Maria Eagle, whose Liverpool Garston constituency includes the Speke site, is reportedly planning a meeting with the government’s Office for Life Sciences to secure the investment. The Treasury has reaffirmed its commitment to making the UK a global leader in the development and manufacture of innovative medicines and confirmed that discussions with AstraZeneca are ongoing.

AstraZeneca, which recently saw its market value surpass £200 billion, declined to comment on the situation. Last month, Soriot indicated that the company was “absolutely ready to go” with the Speke expansion and expressed hope that the government contract could be finalised soon.

Shadow Secretary of State for Science, Innovation and Technology, Andrew Griffith, expressed disappointment, stating that the Treasury’s actions appear to undermine the UK’s ambitions to become a global science and technology leader. He warned that jeopardising AstraZeneca’s plans could threaten a significant British success story.

Read more:
AstraZeneca’s £450 million vaccine plant at risk as government reconsiders financial backing

0
FacebookTwitterGoogle +Pinterest
previous post
Tata Steel workers and suppliers receive £13.5 million in emergency funding amid Port Talbot restructuring
next post
Iran’s new president asserts right to retaliation in rare phone call with major US ally

You may also like

Evening Standard scraps daily print paper blaming work...

May 30, 2024

Business Banking Resolution Service announces Ombudsman Association membership

October 26, 2022

We are heading for significant tax rises, warns...

July 14, 2025

The billion-dollar anime market – an opportunity for...

October 21, 2022

Respect the menopause or be sued for disability...

February 22, 2024

Copper Mountain Technologies Focuses on Enabling Engineers in...

February 12, 2025

Royal Mail and BT awarded £20m in lorry...

February 9, 2023

Business confidence hits highest level since October budget...

May 1, 2025

The Top 5 Cybersecurity Threats and How to...

December 27, 2024

How a Compliance Expert Can Streamline UK Company...

October 14, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Republican senator claims RFK Jr. mRNA vaccine decision undermines Trump agenda

      August 7, 2025
    • Who is Anita Dunn? The Biden confidante who clashed with Hunter grilled in House autopen probe

      August 7, 2025
    • Case v. Montana Brief: Limit Loopholes to the Fourth Amendment

      August 7, 2025
    • Trump opens $9tn US retirement market to crypto in landmark executive order

      August 7, 2025
    • What Should We Learn from China’s Nuclear Construction Costs?

      August 7, 2025
    • Closing the Primary Care Gap

      August 7, 2025

    Categories

    • Business (8,704)
    • Investing (2,182)
    • Politics (16,333)
    • Stocks (3,228)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved